STAT Plus: Madrigal wins first U.S. approval for drug to treat liver disease MASH
Rezdiffra, a pill developed by Madrigal Pharmaceuticals, targets a protein directly in the liver that reduces liver fat, inflammation, and scarring.
Read The StoryFDA
FDA news roundup. Food and Drug Administration stories include proposed changes to nutrition fact labels, the safety of the pharmaceutical supply chain, regulating high blood pressure devices, and a fact check on Vivek Ramaswamy’s call to gut the FDA.
Other stories include FDA approval of Pfizer’s RSV vaccine, an approved treatment for a rare bone disease, and a warning over misleading promotional materials for a COPD drug.
STAT Plus: What happens when an approved drug doesn’t work?
STAT Plus: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next
STAT Plus: In stunning outcome, Amylyx’s ALS drug fails large clinical trial
STAT Plus: FDA clears first over-the-counter continuous glucose monitor
All Coverage
advertisement
